Study Looking at Individuals with Multiple Sclerosis

What we are studying

The main purpose of this study is to compare two different drugs to evaluate the effectiveness and safety of these drugs on relapsing-remitting multiple sclerosis (RRMS).

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 65

Eligibility Criteria

  • Ages 18-65
  • Patients with RRMS

What is involved

  • Screening period
  • Dosing period
  • Follow-Up visit
  • Total of 8 visits over 15 months


$240 for completing all scheduled study visits,if you withdraw before completion of the study you will be paid $30 for each complete study visit

Contact Information

Study Coordinator
Janet Hutchens

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.